Circulating biomarkers from tumour bulk to tumour machinery: Promises and pitfalls

M. Gion, M. G. Daidone

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

In this paper, we provide a working classification for circulating biomarkers according to their potential clinical application. We broadly divided biomarkers into four groups: (i) biomarkers of cancer risk, (ii) biomarkers of tumour-host interactions, (iii) biomarker of tumour burden, and (iv) function-related biomarkers. We hope this classification will provide a framework to which the results of future studies can be added. We also discuss the promises and pitfalls in the optional use of biomarkers in oncology.

Original languageEnglish
Pages (from-to)2613-2622
Number of pages10
JournalEuropean Journal of Cancer
Volume40
Issue number17 SPEC. ISS.
DOIs
Publication statusPublished - Nov 2004

Fingerprint

Tumor Biomarkers
Biomarkers
Neoplasms
Tumor Burden

Keywords

  • Biomarkers
  • Cancer
  • Classification
  • Pitfalls

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Circulating biomarkers from tumour bulk to tumour machinery : Promises and pitfalls. / Gion, M.; Daidone, M. G.

In: European Journal of Cancer, Vol. 40, No. 17 SPEC. ISS., 11.2004, p. 2613-2622.

Research output: Contribution to journalArticle

@article{9b5a4795b9e747eb99a7a8b125511c62,
title = "Circulating biomarkers from tumour bulk to tumour machinery: Promises and pitfalls",
abstract = "In this paper, we provide a working classification for circulating biomarkers according to their potential clinical application. We broadly divided biomarkers into four groups: (i) biomarkers of cancer risk, (ii) biomarkers of tumour-host interactions, (iii) biomarker of tumour burden, and (iv) function-related biomarkers. We hope this classification will provide a framework to which the results of future studies can be added. We also discuss the promises and pitfalls in the optional use of biomarkers in oncology.",
keywords = "Biomarkers, Cancer, Classification, Pitfalls",
author = "M. Gion and Daidone, {M. G.}",
year = "2004",
month = "11",
doi = "10.1016/j.ejca.2004.07.031",
language = "English",
volume = "40",
pages = "2613--2622",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "17 SPEC. ISS.",

}

TY - JOUR

T1 - Circulating biomarkers from tumour bulk to tumour machinery

T2 - Promises and pitfalls

AU - Gion, M.

AU - Daidone, M. G.

PY - 2004/11

Y1 - 2004/11

N2 - In this paper, we provide a working classification for circulating biomarkers according to their potential clinical application. We broadly divided biomarkers into four groups: (i) biomarkers of cancer risk, (ii) biomarkers of tumour-host interactions, (iii) biomarker of tumour burden, and (iv) function-related biomarkers. We hope this classification will provide a framework to which the results of future studies can be added. We also discuss the promises and pitfalls in the optional use of biomarkers in oncology.

AB - In this paper, we provide a working classification for circulating biomarkers according to their potential clinical application. We broadly divided biomarkers into four groups: (i) biomarkers of cancer risk, (ii) biomarkers of tumour-host interactions, (iii) biomarker of tumour burden, and (iv) function-related biomarkers. We hope this classification will provide a framework to which the results of future studies can be added. We also discuss the promises and pitfalls in the optional use of biomarkers in oncology.

KW - Biomarkers

KW - Cancer

KW - Classification

KW - Pitfalls

UR - http://www.scopus.com/inward/record.url?scp=8444222365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8444222365&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2004.07.031

DO - 10.1016/j.ejca.2004.07.031

M3 - Article

C2 - 15541962

AN - SCOPUS:8444222365

VL - 40

SP - 2613

EP - 2622

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 17 SPEC. ISS.

ER -